[Initial evaluation of the ACL-Futura coagulation analyzer].

Purpose: The first analytical performance of analyzer ACL-Futura (Instruments Laboratory) is presented.

Results: The analyzer shows an within-between day imprecision with controls, for PT (prothrombin time) of 0.7-8%, APTT (activated partial thromboplastin time) of 0.7-4%, fibrinogen (derived) 2-6%, ATIII (antithrombin III) of 3-9%, with specimens the imprecision is lowest. The linearity and carry-over for all the techniques were studied. An study of medicine interferences (Aspirin and Sintrom) and bilirubin, lipemia was performed. The reference values are presented. We study the practicability of the analyzer: technical difficulty, time consuming, determination cost and the usefulness in the urgency laboratory.

Conclusion: These results validate the method to resolve the increased demand of these parameters.